CD4 and lung cancer: Several studies have also reported that the CD4+/CD25(high)/FoxP3+/CD127- Tregs content is related to the prognosis of lung cancer patients, and the number of Tregs in the bronchoalveolar lavage fluid of patients with lung cancer has been found to be higher than that of patients with benign lesions [59].